Medibloom Pharmachem Private Limited
About Medibloom Pharmachem Private Limited
Data last updated:
Medibloom Pharmachem Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24304HP2019PTC007652.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Omprakash and Manish Gahlot.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1227 Opposite Unichem Village Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.68 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹68,783 (net margin 0.4%) and EBITDA of ₹1.16 Lakh (EBITDA margin 0.7%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years.
Company details
Contact details
Medibloom Pharmachem Private Limited's registered office is in Baddi, Himachal Pradesh.
- Registered Address1227 Opposite Unichem Village Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medibloom Pharmachem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medibloom Pharmachem Private Limited, buy the company report.
Financials of Medibloom Pharmachem Private Limited
FY 2025 filings availableMedibloom Pharmachem Private Limited reported revenue of ₹1.68 Cr (up 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 11% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 30%. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68,783 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medibloom Pharmachem Private Limited, buy the company report.
Board of directors of Medibloom Pharmachem Private Limited
Medibloom Pharmachem has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Omprakash | Director | 21 Mar 2025 | 1 Years 7 Months | Current |
| Manish Gahlot | Director | 21 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Medibloom Pharmachem Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medvue Remedies Private Limited | ₹1.68 Cr (FY 2025) | 114.0% | Ahmedabad, Gujarat, India | |||
| Ms Suraj Pharmaceuticals (India) Private Limited | ₹1.68 Cr (FY 2024) | -2.0% | Patna, Bihar, India | |||
| Saj Propack Private Limited | ₹1.68 Cr (FY 2025) | -23.0% | Kulgachia, West Bengal, India | |||
| Axon Laboratories Private Limited | ₹1.68 Cr (FY 2024) | 58.0% | Punjab, India | |||
| Blissbury Care Private Limited | ₹1.68 Cr (FY 2025) | 44.0% | Bhopal, Madhya Pradesh, India | |||
| Medibloom Pharmachem Private Limitedthis company | ₹1.68 Cr (FY 2024) | ₹68,783 | 0.4% | 11.0% | Baddi, Himachal Pradesh, India | |
| Adilios Life Science Private Limited | ₹1.68 Cr (FY 2025) | 52.0% | Ahmedabad, Gujarat, India | |||
| Medvey Biotech Private Limited | ₹1.68 Cr (FY 2024) | 118.0% | Kudus, Maharashtra, India | |||
| Bacs Research Lab Private Limited | ₹1.68 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Gamoxo Home Care Private Limited | ₹1.68 Cr (FY 2017) | Indore, Madhya Pradesh, India | ||||
| Yogi International Private Limited | ₹1.68 Cr (FY 2025) | 42.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Medibloom Pharmachem Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medibloom Pharmachem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medibloom Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medibloom Pharmachem Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medibloom Pharmachem Private Limited has 8 board changes on record since 2022: 3 appointments and 5 cessations. The latest: Seema Jakhar ceased to be Director on 05 Apr 2025.
Frequently asked questions
Medibloom Pharmachem is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 October 2019 (7+ years old) and is registered under CIN U24304HP2019PTC007652.
Medibloom Pharmachem has 2 current directors:
- Omprakash - Director
- Manish Gahlot - Director
The latest financial statements of Medibloom Pharmachem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Medibloom Pharmachem is U24304HP2019PTC007652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medibloom Pharmachem was incorporated on 14 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Medibloom Pharmachem by revenue are Medvue Remedies Private Limited, Ms Suraj Pharmaceuticals (India) Private Limited, Saj Propack Private Limited, Axon Laboratories Private Limited, Blissbury Care Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Seema Jakhar ceased to be Director on 05 Apr 2025. Laxmi Narayan Jakhar ceased to be Director on 21 Mar 2025. Manish Gahlot was appointed as Director on 21 Mar 2025. Medibloom Pharmachem has 8 board changes on record in total.
The registered office of Medibloom Pharmachem is at 1227 Opposite Unichem Village Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205.
Medibloom Pharmachem operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Medibloom Pharmachem can be reached at its registered office: 1227 Opposite Unichem Village Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205.
Medibloom Pharmachem is registered under the jurisdiction of the Registrar of Companies (ROC), Himachal Pradesh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
